David E. Dawe

1.2k total citations
56 papers, 749 citations indexed

About

David E. Dawe is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Epidemiology. According to data from OpenAlex, David E. Dawe has authored 56 papers receiving a total of 749 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Pulmonary and Respiratory Medicine, 21 papers in Oncology and 10 papers in Epidemiology. Recurrent topics in David E. Dawe's work include Lung Cancer Treatments and Mutations (15 papers), Lung Cancer Research Studies (12 papers) and Occupational and environmental lung diseases (7 papers). David E. Dawe is often cited by papers focused on Lung Cancer Treatments and Mutations (15 papers), Lung Cancer Research Studies (12 papers) and Occupational and environmental lung diseases (7 papers). David E. Dawe collaborates with scholars based in Canada, France and United States. David E. Dawe's co-authors include Peter Ellis, Clinton S. Robbins, Mahmoud A. Pouladi, Martin R. Stämpfli, Anna G. Drannik, Susanna Goncharova, Gerard Cox, Filip K. Świrski, Craig Harlos and Gregory R. Pond and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

David E. Dawe

50 papers receiving 729 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David E. Dawe Canada 15 280 212 132 110 106 56 749
Jeroen Mebis Belgium 19 261 0.9× 448 2.1× 119 0.9× 98 0.9× 38 0.4× 65 973
Lorenzo Dottorini Italy 13 143 0.5× 330 1.6× 90 0.7× 61 0.6× 48 0.5× 42 664
Ian Nivison‐Smith Australia 18 70 0.3× 280 1.3× 74 0.6× 121 1.1× 109 1.0× 39 868
Chi Hoon Maeng South Korea 19 212 0.8× 258 1.2× 73 0.6× 109 1.0× 27 0.3× 80 758
Theodore T. Suh United States 14 199 0.7× 116 0.5× 59 0.4× 73 0.7× 50 0.5× 23 1.0k
Steven Habbous Canada 18 336 1.2× 296 1.4× 148 1.1× 284 2.6× 30 0.3× 67 1.1k
Kayo Nakata Japan 13 295 1.1× 302 1.4× 87 0.7× 130 1.2× 24 0.2× 50 856
Liyan Liu China 14 144 0.5× 188 0.9× 101 0.8× 93 0.8× 59 0.6× 31 660
Jerzy Kozielski Poland 15 434 1.6× 182 0.9× 111 0.8× 98 0.9× 67 0.6× 98 810
Akhil Kapoor India 14 240 0.9× 340 1.6× 69 0.5× 193 1.8× 22 0.2× 154 683

Countries citing papers authored by David E. Dawe

Since Specialization
Citations

This map shows the geographic impact of David E. Dawe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Dawe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Dawe more than expected).

Fields of papers citing papers by David E. Dawe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David E. Dawe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Dawe. The network helps show where David E. Dawe may publish in the future.

Co-authorship network of co-authors of David E. Dawe

This figure shows the co-authorship network connecting the top 25 collaborators of David E. Dawe. A scholar is included among the top collaborators of David E. Dawe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David E. Dawe. David E. Dawe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ouellette‐Kuntz, Hélène, Rebecca Griffiths, Julie Hallet, et al.. (2025). Frequency of Missing TNM Stage Data for Adults With Intellectual or Developmental Disabilities in a Provincial Cancer Registry—A Brief Report. Cancer Medicine. 14(1). e70579–e70579. 1 indexed citations
2.
Meyers, Daniel E., et al.. (2024). Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer Under-Represented by Clinical Trials. Current Oncology. 31(9). 5498–5515.
3.
Wu, Xun, Sen Hou, Spencer B. Gibson, et al.. (2023). Elevated expression of interleukin 16 in chronic lymphocytic leukemia is associated with disease burden and abnormal immune microenvironment. Leukemia Research. 131. 107315–107315. 4 indexed citations
4.
Yang, Jiayu, Lin Yang, Oliver Bucher, et al.. (2023). Clinical Outcomes in a Large Canadian Centralized CLL Clinic Based on Treatment and Molecular Factors over a Decade. Current Oncology. 30(7). 6411–6431.
5.
Melosky, Barbara, Natasha B. Leighl, David E. Dawe, et al.. (2023). Canadian Consensus Recommendations on the Management of Extensive-Stage Small-Cell Lung Cancer. Current Oncology. 30(7). 6289–6315. 6 indexed citations
6.
Mahar, Alyson, Shelley Derksen, Rebecca Griffiths, et al.. (2023). Stage IV breast, colorectal, and lung cancer at diagnosis in adults living with intellectual or developmental disabilities: A population‐based cross‐sectional study. Cancer. 130(5). 740–749. 11 indexed citations
7.
Dawe, David E., et al.. (2023). Real-world predictors of survival in patients with extensive-stage small-cell lung cancer in Manitoba, Canada: a retrospective cohort study. Frontiers in Oncology. 13. 1191855–1191855. 4 indexed citations
8.
Banerji, Shantanu, Daniel E. Meyers, Craig Harlos, & David E. Dawe. (2021). The Role of Immunotherapy in the Treatment of Malignant Pleural Mesothelioma. Current Oncology. 28(6). 4542–4551. 4 indexed citations
9.
Kushnir, Igal, Naveen S. Basappa, Sunita Ghosh, et al.. (2021). Active Surveillance in Metastatic Renal Cell Carcinoma: Results From the Canadian Kidney Cancer Information System. Clinical Genitourinary Cancer. 19(6). 521–530. 12 indexed citations
10.
Okoli, George N., Olt Lam, Leslie Copstein, et al.. (2021). Integration of geriatric assessment into clinical oncology practice: A scoping review. Current Problems in Cancer. 45(3). 100699–100699. 8 indexed citations
11.
Ouellette‐Kuntz, Hélène, Julie Hallet, Shahin Shooshtari, et al.. (2021). A scoping review documenting cancer outcomes and inequities for adults living with intellectual and/or developmental disabilities. European Journal of Oncology Nursing. 54. 102011–102011. 14 indexed citations
12.
Chowdhury, Subir Roy, Zoann Nugent, Edgard M. Mejia, et al.. (2020). Mitochondrial Respiration Correlates with Prognostic Markers in Chronic Lymphocytic Leukemia and Is Normalized by Ibrutinib Treatment. Cancers. 12(3). 650–650. 17 indexed citations
13.
Banerji, Shantanu, et al.. (2020). Immunotherapy Benefit in a Patient With Non-Small Cell Lung Cancer and a Rare BRAF Mutation. Cureus. 12(10). e11224–e11224. 6 indexed citations
14.
Linton, Janice, Hélène Ouellette‐Kuntz, Shahin Shooshtari, et al.. (2019). Scoping review protocol documenting cancer outcomes and inequalities for adults living with intellectual and/or developmental disabilities. BMJ Open. 9(11). e032772–e032772. 6 indexed citations
15.
16.
Banerji, Shantanu, et al.. (2018). P1.12-08 The Effect of Cisplatin Versus Carboplatin on Cancer Outcomes for Small Cell Lung Cancer Patients in a Population-Based Cohort. Journal of Thoracic Oncology. 13(10). S576–S576. 2 indexed citations
17.
Kim, Julian, et al.. (2017). P2.01-038 Discrimination of NSCLC Cases from Cancer-Free Controls and Adenocarcinoma from Squamous Cell Carcinoma Using Plasma Metabolomics Profiles. Journal of Thoracic Oncology. 12(1). S808–S809. 1 indexed citations
18.
Dawe, David E., Gregory R. Pond, & Peter Ellis. (2016). Assessment of Referral and Chemotherapy Treatment Patterns for Elderly Patients With Non–small-Cell Lung Cancer. Clinical Lung Cancer. 17(6). 563–572.e2. 22 indexed citations
19.
Dawe, David E., David Christiansen, Anand Swaminath, et al.. (2016). Chemoradiotherapy versus radiotherapy alone in elderly patients with stage III non-small cell lung cancer: A systematic review and meta-analysis. Lung Cancer. 99. 180–185. 34 indexed citations
20.
Dawe, David E. & Peter Ellis. (2014). The Treatment of Metastatic Non-Small Cell Lung Cancer in the Elderly: An Evidence-Based Approach. Frontiers in Oncology. 4. 178–178. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jeroen Mebis Breakdown of academic impact, for papers by Lorenzo Dottorini Breakdown of academic impact, for papers by Ian Nivison‐Smith Breakdown of academic impact, for papers by Chi Hoon Maeng Breakdown of academic impact, for papers by Theodore T. Suh Breakdown of academic impact, for papers by Steven Habbous Breakdown of academic impact, for papers by Kayo Nakata Breakdown of academic impact, for papers by Liyan Liu Breakdown of academic impact, for papers by Jerzy Kozielski Breakdown of academic impact, for papers by Akhil Kapoor
Rankless by CCL
2026